Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Carcinoma, Renal Cell 12Prostatic Neoplasms 4Kidney Neoplasms 4Neoplasms 3Carcinoma, Hepatocellular 3Sarcoma, Ewing 2Osteosarcoma 2Neuroendocrine Tumors 2Neoplasm Metastasis 2Melanoma 2Lung Neoplasms 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Medullary 2Carcinoma 2Adrenocortical Carcinoma 2von Hippel-Lindau Disease 1Wilms Tumor 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Urachal adenocarcinoma 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma, Clear Cell 1

Interventions

cabozantinib 4Nivolumab 2Ipilimumab 2zimberelimab 1temsirolimus 1salicylhydroxamic acid 1orellanine 1atezolizumab 1Surveys and Questionnaires 1Ropivacaine 1Pluvicto 1Methods 1Health Promotion 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Erlotinib Hydrochloride 1Educational Status 1Early Intervention, Educational 1Docetaxel 1Dacarbazine 1Counseling 1Blood Component Removal 1Axitinib 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Kidney Neoplasms × cabozantinib × 30 days × Clear all
NCT04322955 2026-06-05

Cyto-KIK

Columbia University

Phase 2 Active not recruiting
38 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07028125 2026-06-05

CANIQOL

Centre Francois Baclesse

Phase 4 Recruiting
83 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT07011719 2026-06-02

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Arcus Biosciences, Inc.

Phase 3 Recruiting
720 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

NCT05536141 2026-06-01

ARC-20

Arcus Biosciences, Inc.

Phase 1 Recruiting
362 enrolled
Genitourinary

Erythrocytosis, Familial, 4, Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡